Search

Your search keyword '"Spierings EL"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Spierings EL" Remove constraint Author: "Spierings EL"
150 results on '"Spierings EL"'

Search Results

1. A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain.

2. Comparison of Therapeutic Gain With Therapeutic Ratio for the Assessment of Selective 5HT1B/1D Agonist Efficacy in Migraine.

3. The management of os odontoideum. Analysis of 37 cases

5. The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments.

6. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.

7. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.

8. Classification and Differential Diagnosis of Oral and Maxillofacial Pain.

10. De Novo Headache During Pregnancy and Puerperium.

11. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

12. Menstrual-Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study.

13. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.

14. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.

15. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).

17. Orofacial pain after invasive dental procedures: neuropathic pain in perspective.

18. Sufficiency and necessity in migraine: how do we figure out if triggers are absolute or partial and, if partial, additive or potentiating?

19. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

20. A randomized, rater-blinded, crossover study of the effects of oxymorphone extended release, fed versus fasting, on cognitive performance as tested with CANTAB in opioid-tolerant subjects.

21. Daily triptan use for intractable migraine.

22. Headache and insomnia: their relation reviewed.

23. Hemicrania continua should not be classified as a trigeminal autonomic cephalalgia.

24. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine.

25. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

26. Ask the doctor. I have heard that one symptom of a stroke is "the worst headache you can imagine." I recently had a migraine that was so much more painful than previous ones that I worried it was a stroke. Is there any way to tell a migraine from a "stroke headache"?

27. Orofacial pain following an invasive dental procedure.

29. Course of frequent/daily headache in the general population and in medical practice.

32. Headache in men: forgotten in practice and ignored in research.

33. Management of daily headache unresponsive to preventive treatment: daily triptans versus daily opioids.

34. Headache - chronic cluster headache: preventive treatment.

35. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.

36. Migraine: migraine headache pathogenesis in historical perspective.

37. Acupuncture for tension-type headache: a meta-analysis of randomized, controlled trials.

38. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis.

39. Two-minute skin anesthesia through ultrasound pretreatment and iontophoretic delivery of a topical anesthetic: a feasibility study.

40. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

41. Prognostic factors, disability, and functional status among patients in a headache specialty practice.

42. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.

43. Migraine during pregnancy: options for therapy.

44. The aura-headache connection in migraine: a historical analysis.

45. Consequences of transforming measures of efficacy for acute therapies: 5-HT agonists as a worked example.

46. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.

47. Non-lateralized pain in a case of chronic paroxysmal hemicrania?

48. Acute, subacute, and chronic headache.

49. Migraine mechanism and management.

50. Treatment and outcome of chronic daily headache.

Catalog

Books, media, physical & digital resources